VELARU MANDATE EXHIBIT PACK — DIGITAL PATHOLOGY AI
Jurisdiction: Singapore (sg)
Modality: Text / Chat
Program: Velaru Digital Pathology AI · Singapore (galactic_pathology_ai_sg)
Product ID: pathology_ai:sg:bundle:text
Vertical: pathology_ai
Generated: 2026-08-23T20:05:44.144572Z
Authority: Singapore MAS FEAT Pack — Digital Pathology AI External Validation Pack
Deadline: IMDA AI Verify + Model AI Governance Framework
Velaru verify: https://velaru-erra.onrender.com/verify

EXHIBIT A — AI INVENTORY
[]

EXHIBIT B — GOVERNANCE FRAMEWORK
{
  "framework": "Velaru Mandate Registry \u2014 Digital Pathology AI",
  "exhibit_authority": "Singapore MAS FEAT Pack \u2014 Digital Pathology AI External Validation Pack",
  "regulatory_frameworks": [
    "HIPAA",
    "FDA SaMD guidance",
    "EU AI Act Annex III",
    "Model AI Governance Framework",
    "MAS FEAT principles",
    "PDPA"
  ],
  "standards_alignment": [
    "POSS-2",
    "DRP-1",
    "TCB",
    "FRE 707 pre-compliance",
    "ISO 42001"
  ],
  "human_oversight": "execute Digital Pathology AI AI decision",
  "third_party_verification": "https://velaru-erra.onrender.com/verify (operator-independent)",
  "data_lineage": "Hash-chained Ed25519 receipts; optional RFC3161 + external anchor",
  "mirror_trap": "Niche Digital Pathology AI deployer owns AI harm \u2014 vertical SaaS vendor owns liability cap. \u00b7 Singapore positions as AI hub \u2014 AI Verify program needs external validation partner architecture.",
  "chain_integrity": {
    "depth": 6,
    "invariant_holds": true
  }
}

EXHIBIT D — DATA INPUTS & VALIDATION
{
  "data_validation_method": "Cryptographic receipt per AI decision; public verify without trusting deployer, vendor, or Velaru operator",
  "bias_testing_proxy": "Asymmetry score from live chain signals",
  "model_change_control": "Policy lock registry \u2014 criteria hash frozen pre-dispute",
  "logging_retention": "90-day pre-dispute window minimum; permanent verify permalinks",
  "external_validator": "Nisaba LLC / Velaru",
  "validator_independence": "Client-side Ed25519 verify; BYOK tri-receipt optional",
  "headline_stat": "Digital Pathology AI \u2014 AI decision audit trail required for liability defense",
  "global_leaders_addressed": [
    "Sector regulators",
    "Vertical SaaS platforms",
    "MAS",
    "IMDA",
    "DBS",
    "Grab"
  ]
}

MIRROR TRAP (regulatory insight)
Niche Digital Pathology AI deployer owns AI harm — vertical SaaS vendor owns liability cap. · Singapore positions as AI hub — AI Verify program needs external validation partner architecture.

NERVE CARDS — WHY GLOBAL LEADERS CARE
[
  {
    "title": "Niche litigation",
    "body": "Digital Pathology AI plaintiffs challenge AI decision without independent verify.",
    "source": "vertical"
  },
  {
    "title": "Insurance bind",
    "body": "Sector insurers asking AI governance questions on Digital Pathology AI accounts.",
    "source": "vertical"
  },
  {
    "title": "[Singapore] MAS financial",
    "body": "Singapore banking AI \u2014 MAS expects explainability for credit and trading.",
    "source": "jurisdiction"
  },
  {
    "title": "[Singapore] ASEAN hub",
    "body": "Singapore receipts accepted as regional standard across ASEAN deployments.",
    "source": "jurisdiction"
  },
  {
    "title": "[Text / Chat] Modality hook",
    "body": "Baseline \u2014 all frameworks apply to text decisions.",
    "source": "modality"
  }
]

BOOK SUMMARY: {
  "total_insureds": 0,
  "compliant": 0,
  "grace_period": 0,
  "non_compliant": 0,
  "expired": 0,
  "not_enrolled": 0,
  "compliant_pct": 0.0
}

TAM / EXPOSURE: Global Digital Pathology AI market
INSURANCE LINES: E&O, Cyber, Sector liability

DISCLAIMER: External validation evidence pack — not legal advice, not filed rate approval.